Olutasidenib in combination with azacitidine induces durable complete remissions in patients with relapsed or refractory mIDH1 acute myeloid leukemia: a multicohort open-label phase 1/2 trial

Authors

Institutions

Publication Details

Journal
Journal of Hematology & Oncology
Published
2025-01-16
DOI
https://doi.org/10.1186/s13045-024-01657-z
Citations
12
Primary Topic
Acute Myeloid Leukemia Research
Type
article
Field-Weighted Citation Impact
21.24

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Olutasidenib in combination with azacitidine induces durable complete remissions in patients with relapsed or refractory mIDH1 acute myeloid leukemia: a multicohort open-label phase 1/2 trial

Pau Montesinos, William Blum, P. Brent Ferrell, Gail J. Roboz et al.
12 citations
Journal of Hematology & Oncology
Acute Myeloid Leukemia Research
21.24
article

Olutasidenib in combination with azacitidine induces durable complete remissions in patients with relapsed or refractory mIDH1 acute myeloid leukemia: a multicohort open-label phase 1/2 trial

Pau Montesinos, William Blum, P. Brent Ferrell, Gail J. Roboz, Justin M. Watts, Jörge E. Cortes, Stéphane de Botton, Alice S. Mims, Hua Tian, Jay Yang, Aaron Sheppard, Gary J. Schiller, Eunice S. Wang, Maria R. Baer, Karen W L Yee, Brian A. Jonas, Antonio Curti
article en
12 citations

Abstract

No abstract available for this paper.
Journal of Hematology & OncologyVol. 18(1)
University of Maryland, Baltimore (US), Roswell Park Comprehensive Cancer Center (US), Emory Healthcare (US), University of Miami (US), Cornell University (US), Augusta University (US), Ronald Reagan UCLA Medical Center (US), Institut Gustave Roussy (FR), Princess Margaret Cancer Centre (CA), Hospital Universitari i Politècnic La Fe (ES), Augusta University Health (US), The Barbara Ann Karmanos Cancer Institute (US), Azienda USL di Bologna (IT), National Cancer Center of Georgia (GE), Sylvester Comprehensive Cancer Center (US), Rigel (United States) (US), Winship Cancer Institute, The Ohio State University (US), University of California, Davis (US), Vanderbilt University Medical Center (US)
Bristol-Myers Squibb, Pfizer, GlaxoSmithKline, Leukemia and Lymphoma Society, Celgene, Jazz Pharmaceuticals, Foghorn Therapeutics, Syndax Pharmaceuticals, Daiichi-Sankyo, Astellas Pharma, Servier, Genentech
Openalex Percentile: Top 1%
Acute Myeloid Leukemia Research
21.24
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.